appear
viral
mutant
resist
antivir
compound
major
public
health
concern
continu
gener
mutant
characterist
rna
virus
mani
exampl
hepat
c
viru
hcv
human
immunodefici
viru
hiv
denv
posit
rna
genom
caus
seriou
diseas
genom
rna
virus
act
templat
replic
mrna
replic
mutat
introduc
genom
via
error
action
viral
rna
polymeras
gener
mutant
may
greatli
contribut
viral
also
lead
disappear
viru
chang
leav
induc
acut
pathogenesi
host
error
catastroph
review
see
virus
must
therefor
strive
reach
equilibrium
allow
adapt
fit
without
compromis
persist
accomplish
rna
virus
develop
inform
storag
system
code
protein
specif
complex
highli
conserv
fold
genom
region
play
direct
function
role
viral
cycl
viral
region
present
adapt
behaviour
evolv
select
pressur
achiev
high
genet
robust
result
mutat
viral
rna
genom
present
minor
incid
function
element
rna
molecul
show
two
level
compact
secondari
tertiari
structur
secondari
structur
result
region
arrang
exampl
helic
close
loop
tertiari
structur
determin
relationship
establish
secondari
structur
element
combin
two
fold
level
establish
final
shape
rna
molecul
rna
structurom
conform
view
prompt
search
structur
rna
motif
frd
viral
genom
also
transcriptom
live
organ
review
see
main
featur
frd
includ
viral
genom
high
genet
robust
like
deriv
essenti
consecut
infect
cycl
frd
element
typic
involv
interact
requir
correct
execut
regul
essenti
viral
process
one
frd
attract
attent
ire
ire
region
direct
recruit
cellular
translat
machineri
manner
similarli
viral
replic
matur
regul
direct
bind
viral
polymeras
relat
cofactor
frd
end
genom
rna
well
direct
interact
distant
region
viru
genom
function
import
structur
element
viral
cycl
high
conserv
rate
suggest
might
make
good
therapeut
target
idea
develop
novel
antivir
tool
mostli
rna
base
attack
gain
currenc
recent
year
review
briefli
summaris
known
frd
number
virus
pay
special
attent
infect
human
recapitul
state
art
develop
therapeut
compound
might
interfer
frd
fold
therefor
function
mani
viral
genom
achiev
effici
translat
initi
use
iress
replac
if
combin
use
sever
frd
region
present
high
sequenc
structur
divers
across
differ
viral
group
defin
mechan
promot
translat
iress
therefor
divid
four
group
accord
common
requir
figur
pack
iress
group
encompass
ire
element
locat
igr
genom
dicistrovirida
famili
whose
member
infect
insect
fold
element
repres
highli
conserv
compact
structur
via
mechan
mediat
recruit
ribosom
need
addit
protein
factor
ire
structur
split
three
domain
figur
defin
pk
motif
conform
consid
prefold
isoform
ire
domain
pkiii
mimic
fold
initi
transfer
rna
trna
allow
occupi
p
e
site
ribosom
subunit
promot
structur
chang
ire
final
allow
bind
particl
effici
initi
translat
codon
thu
conform
pkiii
replac
need
initi
trna
extend
ire
compact
region
prototyp
group
hcv
ire
fold
extend
region
tightli
compact
domain
mostli
contain
rna
genom
also
span
short
stretch
code
sequenc
figur
b
divid
two
major
domain
ii
iii
short
contain
start
codon
domain
iv
extend
fold
ire
allow
proper
coaxial
align
domain
ii
iii
either
side
complex
pk
structur
allow
easi
access
ribosom
particl
subsequ
ire
conform
chang
directli
posit
appropri
start
codon
p
site
bind
iiiabc
junction
aid
incorpor
ternari
complex
met
join
subunit
review
see
interestingli
requir
met
minimis
certain
stress
condit
provid
select
advantag
effici
hcv
propag
even
unfavour
physiolog
environ
suggest
ire
may
chang
mode
function
depend
environment
condit
flexibl
iress
mainli
repres
picornaviru
type
ii
iress
fmdv
emcv
among
other
figur
c
overal
structur
reflect
greater
degre
flexibl
shown
igr
iress
ribosom
recruit
nonetheless
retain
compact
gnra
sequenc
motif
includ
within
tetraloop
direct
structur
organis
central
domain
flexibl
iress
directli
recruit
ribosom
subunit
rather
first
bind
domain
final
induc
conform
rearrang
promot
recruit
complex
presenc
domain
crucial
bind
addit
itaf
ptb
pabp
itaf
thought
provid
chaperon
activ
may
also
help
overcom
cell
restrict
stress
condit
henc
flexibl
fold
provid
specif
biophys
properti
defin
characterist
mode
action
induc
ire
lentivirus
use
ire
element
restrict
certain
environment
condit
initi
protein
synthesi
normal
accomplish
mechan
two
differ
ire
element
lie
within
hiv
genom
one
oper
phase
cell
cycl
one
embed
within
code
sequenc
figur
enorm
effort
gone
fathom
induct
mechan
element
without
much
success
well
known
rna
adopt
two
differ
conform
direct
translat
regul
mediat
conform
exchang
genom
rna
rule
furthermor
seem
like
unknown
itaf
differenti
load
conform
provid
sophist
opportunist
viral
strategi
aim
overcom
environment
difficulti
tempt
propos
induct
ire
within
code
sequenc
modul
interact
thu
promot
altern
conform
might
regul
function
enteroviru
sp
genu
enteroviru
includ
human
poliovirus
rhinovirus
human
enterovirus
group
b
c
includ
differ
human
coxsackievirus
genom
rna
end
orir
region
compos
short
highli
fold
nucleotid
cap
polya
tail
orir
shown
play
import
role
viral
replic
via
direct
recruit
viral
rna
polymeras
host
cell
factor
pcbp
la
autoantigen
common
architectur
infer
member
viral
group
figur
thu
rhinovirus
singl
name
poliovirus
contain
two
x
coxsackievirus
three
consecut
x
z
presenc
two
defin
typic
pk
motif
involv
apic
loop
domain
x
pk
may
regul
dynam
spatial
rearrang
domain
x
viral
rna
synthesi
despit
sequenc
divers
enteroviru
repres
good
exampl
rna
genom
structur
diversifi
yet
retain
common
essenti
functionsaphthovirus
fmdv
prototyp
aphthoviru
group
genom
contain
essenti
orir
region
end
consist
around
nucleotid
plu
genet
encod
polya
tract
figur
b
adopt
conform
defin
two
recent
shown
wherea
delet
complet
interfer
viru
viabil
mutant
defect
show
reduc
replic
capac
orir
region
aphthovirus
also
involv
translat
control
establish
molecular
bridg
ire
element
end
viral
genom
hepaciviru
sp
hcv
genom
evolutionarili
conserv
structur
element
around
nucleotid
three
differ
domain
figur
c
hv
polyuuc
tract
variabl
length
composit
tail
consist
three
polyuuc
tract
tail
contain
element
import
replic
infect
cell
cultur
chimpanze
model
hepacivirus
oper
recruit
viral
protein
rna
polymeras
helicas
well
numer
host
factor
moreov
format
structur
involv
rna
motif
end
code
sequenc
provid
addit
regul
fold
activ
togeth
aforement
element
constitut
complet
function
scaffold
requir
achiev
precis
rna
replic
flaviviru
sp
genu
includ
import
human
pathogen
denv
yfv
jev
posit
rna
genom
contain
rang
nucleotid
length
despit
heterogen
size
common
secondari
structur
element
found
end
genom
rna
defin
domain
iii
indispens
replic
figur
domain
iii
compos
short
hairpin
follow
long
stabl
shown
format
pk
motif
involv
apic
loop
short
hairpin
intern
loop
critic
recognit
viral
cellular
protein
initi
rna
synthesi
genom
coronavirida
famili
encod
five
seven
overlap
cap
polyadenyl
subgenom
mrna
contain
two
highli
conserv
structur
motif
essenti
bulg
bsl
immedi
follow
hairpin
figur
e
certain
condit
fold
may
displac
toward
format
pk
motif
base
first
domain
apic
loop
hairpin
lead
conform
equilibrium
must
preserv
rna
replic
occur
posit
pk
hvr
found
highli
diverg
term
primari
secondari
structur
except
motif
octanucleotid
situat
nucleotid
end
coronaviru
genom
thu
consid
characterist
signatur
pathogen
agent
stringent
conserv
impli
critic
yet
unknown
function
coronaviru
biolog
long
list
viral
cellular
protein
also
bind
differ
coronaviru
affect
replic
includ
viral
rna
polymeras
viru
protein
nuclear
factor
protein
involv
translat
process
thu
interact
provid
complex
regulatori
network
control
viral
infect
recent
work
shown
great
varieti
rna
motif
embed
throughout
code
sequenc
oper
coordin
fashion
function
region
viral
host
protein
provid
complex
control
system
replic
cre
found
picornaviru
genom
contain
one
short
hairpin
respons
effici
prime
rna
synthesi
two
adenin
residu
place
apic
loop
one
hairpin
function
templat
uridylyl
essenti
viral
protein
vpg
involv
picornavir
replic
mechan
shown
contribut
overcom
effect
low
nucleotid
concentr
thu
provid
robust
system
initi
replic
cre
identifi
within
end
code
sequenc
hcv
genom
highli
conserv
structur
compos
three
figur
shown
requir
viral
replic
establish
interact
within
hairpin
motif
code
sequenc
critic
proper
function
region
viral
rna
synthesi
figur
importantli
exist
addit
direct
interact
involv
subdomain
iiid
ire
essenti
cre
region
import
consequ
regul
hcv
ire
function
figur
commun
viral
genom
directli
respons
promot
regul
differ
step
infecti
cycl
via
establish
contact
differenti
evolv
function
region
end
viral
genom
act
coordin
fashion
gener
molecular
switch
control
system
differ
step
viral
cycl
crosstalk
seem
provid
import
benefit
increas
local
concentr
essenti
protein
cofactor
addit
protect
action
exonucleas
genom
circularis
provid
new
proof
great
versatil
shown
compact
viral
rna
genom
format
circular
topolog
picornavirus
depend
direct
rna
contact
ire
figur
b
furthermor
rna
bind
capac
differ
factor
ire
region
pabp
polya
tail
ensur
stabil
conform
hepaciviru
genom
circularis
initi
propos
mediat
protein
factor
alon
would
simultan
bind
end
viral
genom
recent
contact
ire
cre
describ
induc
signific
conform
chang
precis
domain
ire
figur
result
regul
ire
function
undoubtedli
result
exclud
particip
viral
cellular
protein
stabilis
circular
topolog
perform
import
function
role
virus
flaviviru
sp
rna
genom
circularis
requir
presenc
protein
use
canon
complementari
sequenc
cyclis
sequenc
upstream
aug
region
downstream
aug
region
either
end
viral
genom
figur
c
motif
achiev
associ
genom
termini
direct
base
pair
topolog
essenti
viral
propag
could
advantag
regul
viral
translat
rna
synthesi
well
control
switch
differ
step
viral
cycl
nucleic
acid
particularli
rna
excel
candid
develop
antivir
agent
target
function
region
viral
genom
success
strategi
reli
sequenc
complementar
andor
structur
recognit
inhibitor
target
therefor
highli
conserv
genom
domain
promis
region
target
new
antivir
compound
importantli
number
aspect
need
taken
account
pursu
goal
cellular
uptak
inhibitor
target
inhibitor
colocalis
activ
inhibitor
concentr
insid
cell
intracellular
inhibitor
stabil
access
bind
target
region
recent
year
great
progress
made
field
nucleic
acid
treatment
aforement
problem
success
solv
led
design
new
gener
antivir
rna
dna
drug
current
extens
develop
antisens
oligonucleotid
antisens
oligonucleotid
short
nucleic
acid
molecul
whose
sequenc
complementari
exist
motif
target
rna
molecular
mechan
action
antisens
oligonucleotid
divers
figur
act
hide
essenti
site
viral
genom
rna
requir
protein
synthesi
replic
packag
dna
base
induc
target
degrad
mediat
rnase
h
antisens
oligonucleotid
administ
either
directli
subcutan
inject
pharmacolog
composit
context
great
advanc
combinatori
chemistri
allow
develop
oligonucleotid
chemic
substitut
precis
posit
modif
confer
import
featur
signific
increas
serum
higher
thermal
stabil
duplex
strategi
follow
mchutchinson
et
al
design
compound
low
success
phase
clinic
trial
differ
administr
strategi
base
intracellular
product
unmodifi
antisens
oligonucleotid
requir
gene
therapi
protocol
deliv
construct
insid
cell
main
advantag
chimer
construct
encompass
differ
antisens
sequenc
even
differ
inhibitor
produc
thu
target
multipl
site
simultan
use
strategi
may
greatli
contribut
diminish
appear
resist
viral
variant
method
success
use
inhibit
replic
small
interf
rna
sirna
cellular
rnai
pathway
trigger
synthet
sirna
molecul
compound
usual
nucleotid
long
overhang
sirna
load
silenc
complex
sens
guid
strand
select
target
complementari
sequenc
within
genom
viral
rna
degrad
figur
date
numer
studi
conduct
use
sirna
antivir
drug
importantli
previou
advanc
made
therapeut
use
antisens
oligonucleotid
serv
start
point
develop
new
strategi
thu
incorpor
stabilis
chemic
modif
passeng
antisens
strand
may
greatli
increas
potenc
sirna
without
toxic
applic
gene
therapi
strategi
promot
decreas
viral
load
also
studi
sirna
technolog
one
main
drawback
altern
appear
escap
mutant
overcom
problem
sever
strategi
develop
gener
construct
combin
multipl
sirna
target
differ
region
viral
genom
great
potenti
therapeut
prompt
develop
novel
internalis
strategi
allow
antivir
respons
import
contribut
made
field
hcv
infect
exampl
use
nanosom
lipid
nanoparticl
achiev
encapsul
multipl
sirna
deliveri
yield
liver
tumour
xenotranspl
mous
model
hcv
altern
multilay
polyelectrolyt
film
also
shown
effici
way
nucleic
acid
intracellular
deliveri
provid
specif
inhibit
hcv
replic
cell
aptam
aptam
nucleic
acid
bind
specif
ligand
high
affin
isol
selex
vitro
select
strategi
process
consist
iter
seri
synthesi
bind
posit
select
amplif
randomis
oligonucleotid
pool
yield
popul
enrich
molecul
bind
desir
target
molecul
figur
b
strategi
identifi
rna
dna
molecul
potenti
therapeut
use
great
varieti
diseas
includ
mani
viral
infect
addit
aptam
offer
use
inform
architectur
target
molecul
therefor
valuabl
altern
complementari
oligonucleotid
antisens
sirna
aptam
mode
action
depend
fold
mediat
direct
interact
figur
b
block
function
rna
target
domain
either
interf
recruit
essenti
factor
affect
fold
surround
area
thu
imped
interact
may
contribut
diminish
chanc
appear
resist
viral
mutant
among
prefer
viral
target
extens
investig
includ
genom
rna
hiv
hcv
function
rna
region
use
target
aptam
cre
region
hcv
inhibitor
return
promis
result
cell
cultur
vitro
use
produc
antivir
compound
effici
nanomolar
rang
furthermor
research
serv
start
point
develop
novel
strategi
combin
two
inhibitor
rna
molecul
emerg
selex
methodolog
provid
novel
therapeut
diagnost
agent
improv
pharmacokinet
pharmacodynam
properti
low
immunogen
compound
alreadi
investig
sever
compani
possibl
clinic
use
review
conjug
end
aptam
sequenc
stabilis
agent
polyethylen
glycol
shown
effect
pharmacolog
formul
addit
incorpor
ligand
specif
cell
surfac
receptor
help
effici
precis
deliveri
agent
target
cell
type
tissu
given
great
progress
made
field
aptam
may
widespread
use
antivir
agent
futur
use
antibiot
target
rna
structur
element
firstli
describ
aminoglycosid
paromomycin
compound
recognis
aminoacyl
site
bacteri
ribosom
interact
enlarg
deep
grove
defin
two
bulg
one
unpair
adenin
residu
conform
shown
strongli
similar
acquir
dimeris
initi
site
di
complex
model
crystal
structur
resolut
provid
strong
basi
develop
modifi
antivir
deriv
aminoglycosid
accur
view
fold
hiv
di
region
result
greatli
prompt
design
small
improv
ligand
abl
interfer
fold
essenti
di
domain
branch
peptid
common
therapeut
tool
use
develop
synthet
peptid
vaccin
drug
deliveri
vehicl
use
effici
ligand
rna
molecul
associ
multival
target
frd
multipl
interact
site
addit
amino
acid
may
carri
radic
specif
molecular
architectur
increas
target
select
molecul
isol
random
peptid
librari
gener
effici
antivir
compound
target
hiv
respons
element
benzimidazol
nucleu
main
constitu
mani
therapeut
drug
base
combin
heterocycl
compound
yield
isost
natur
occur
nucleotid
chemic
composit
isost
make
benzimidazol
deriv
excel
candid
interact
natur
biopolym
one
deriv
attract
much
attent
recent
year
potenti
molecul
compound
specif
interact
basal
portion
ire
domain
ii
domain
iia
recruit
ribosom
particl
domain
ii
adopt
l
shape
direct
apic
hairpin
loop
iib
toward
subunit
e
site
thu
induc
conform
shift
promot
posit
start
codon
close
activ
site
presenc
domain
iia
acquir
shape
open
helix
alter
proper
fold
domain
ii
thu
imped
correct
posit
viral
rna
catalyt
bind
cleft
find
confirm
import
principl
interf
rna
fold
achiev
inhibitori
effect
compact
rna
viral
genom
provid
import
advantag
term
propag
effici
compact
howev
requir
intervent
supracod
system
ie
inform
genom
beyond
nucleotid
sequenc
direct
fold
requir
without
supracod
system
compact
would
exist
essenti
function
genom
transcript
replic
encapsid
associ
fold
would
lost
structur
conserv
function
rna
element
interact
protein
factor
rna
domain
direct
regul
function
well
switch
differ
step
viral
cycl
interf
function
structur
domain
offer
potenti
mean
treat
viral
infect
great
advanc
made
field
chemic
synthesi
nucleic
acid
product
prompt
novel
initi
involv
small
molecul
alter
conform
viral
genom
rna
domain
might
use
complement
classic
antivir
therapi
use
neutralis
antibodi
interferon
treatment
combin
clinic
strategi
current
extens
investig
aim
improv
therapeut
respons
outcom
minimis
toxic
secondari
effect
author
compet
interest
